Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. ACN
6. III
7. SAN
8. TTEC
9. SNY
10. DAL

Go back to Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 2.98 -0.05 (1.65%)
Previous Close $3.03    52 Week High $3.89 
Open $3.02    52 Week Low $1.85 
Day High $3.08    P/E N/A 
Day Low $2.98    EPS $0.00 
Volume 9,412       

CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 2.98 -0.05 (1.65%)
Previous Close $3.03    52 Week High $3.89 
Open $3.02    52 Week Low $1.85 
Day High $3.08    P/E N/A 
Day Low $2.98    EPS $0.00 
Volume 9,412